RICHMOND, Calif. - WisconsinEagle -- DeepThink Health, Inc., a technology innovator in advanced analytics and artificial intelligence for precision medicine, announced today that Intermountain Healthcare is strengthening its cross-organizational Molecular Tumor Board with the adoption of DeepThink's Precision Tumor Board Solution.
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on Wisconsin Eagle
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on Wisconsin Eagle
- Inc. Magazine Unveils Its Annual List of America's Fastest-Growing Private Companies—the Inc. 5000
- Durham Record Label Maison Fauna Announces Its First Release
- Madison: Demolition of Government East Garage to start week of August 17th
- Public Health Madison & Dane County Announcing Breastfeeding Peer Counseling Program
- Madison: Provisional Voters: Get Your Ballot Counted!
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
Source: DeepThink Health
0 Comments
Latest on Wisconsin Eagle
- Evolve IP® Named For Eighth Time to the Inc. 5000 List of Fastest-Growing Private Companies
- Madison: Mayor Rhodes-Conway's Statement on the Eastside Shooting
- Arrow Organics Reveals 20:1 CBD to THC Product Line
- DelMar Aerospace Corporation Launches New Service: Rapid Deployment Solutions
- Madison: Press Advisory: Stop the Violence & Protect our Youth
- Titletown Manufacturing works with customers to create perfect parts
- Vizient Awards Contract to Surfacide for UV-C Solution That Can Help Hospitals Combat COVID-19
- Annual MSP 501 Identifies Best-in-Class Global MSP Businesses & Leading Trends in Managed Services
- Robinson's new portable fuel trailer is a hit at the lake
- Printers rely on MECA for print sleeves that enhance performance
- Our Madison-Moving Forward Together: Mayor Rhodes-Conway to Address the City on Thursday
- Wisconsin company targets parents with 'unlosable' face masks integrated into children's clothing
- Pvilion Awarded $1.5 Million USAF Phase II SBIR Contract for Autonomously Deployable Structures
- U.S. Army Awards DiSTI $10M Delivery Order for JLTV Trainers
- VORAGO Technologies announces family expansion and size reduction of radiation-hardened Arm® Cortex® MCUs into BGA packages for Defense and Aerospace
- Madison: Voting in the Partisan Primary
- CU Xpress Lease Expands into Northern California
- Grab 'em by the Microphone! Independent Feature Film To the New Girl Releases on VOD
- Crossover Publications announces 9/11/2020 release date for Make America Saved Again
- Madison: Mayor Rhodes-Conway's Letter to the Wisconsin Public Service Commission Requesting an Extension of the Moratorium on Utility Disconnections